Growth Metrics

Sol-Gel Technologies (SLGL) Cash & Equivalents (2016 - 2025)

Sol-Gel Technologies (SLGL) reported Cash & Equivalents of $11.0 million for Q4 2025, down 43.39% year-over-year from $19.5 million in Q4 2024, and up 64.55% on a QoQ basis from $6.7 million in Q3 2025.

Sol-Gel Technologies (SLGL) has 10 years of Cash & Equivalents data on file, last reported at $11.0 million in Q4 2025.

  • Quarterly Cash & Equivalents fell 43.39% year-over-year to $11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.0 million (down 43.39% YoY) and the FY2025 annual result came in at $11.0 million, down 43.39% from the prior year.
  • Cash & Equivalents rose to $11.0 million in Q4 2025 per SLGL's latest filing, from $6.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $43.3 million in Q3 2021 and bottomed at $5.8 million in Q2 2022.
  • The 5-year median for Cash & Equivalents is $12.0 million (2022), against an average of $14.0 million.
  • The widest annual swing landed in 2021, when Cash & Equivalents soared 621.64%; it then sank 80.39% in 2022.
  • Tracing SLGL's Cash & Equivalents over 5 years: stood at $20.1 million in 2021, then plunged by 38.02% to $12.4 million in 2022, then slumped by 39.64% to $7.5 million in 2023, then soared by 159.4% to $19.5 million in 2024, then slumped by 43.39% to $11.0 million in 2025.
  • Per Business Quant, the three latest SLGL Cash & Equivalents figures stand at $11.0 million (Q4 2025), $6.7 million (Q3 2025), and $10.2 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 1.91 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 32.30 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 61.46 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.71 Bn
10 Sol-Gel Technologies 205.76 Mn 194.73 Mn - 11.03 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 11.03 Mn
Sep 30, 2025 6.71 Mn
Jun 30, 2025 10.22 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 19.49 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 11.55 Mn
Mar 31, 2024 11.21 Mn
Dec 31, 2023 7.51 Mn
Sep 30, 2023 14.14 Mn
Jun 30, 2023 15.62 Mn
Mar 31, 2023 6.81 Mn
Dec 31, 2022 12.45 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 5.77 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 20.09 Mn
Sep 30, 2021 43.35 Mn
Jun 30, 2021 11.15 Mn
Mar 31, 2021 12.65 Mn
Dec 31, 2020 7.12 Mn
Sep 30, 2020 6.01 Mn
Jun 30, 2020 5.44 Mn
Mar 31, 2020 2.20 Mn
Dec 31, 2019 9.41 Mn
Sep 30, 2019 7.64 Mn
Jun 30, 2019 14.39 Mn
Mar 31, 2019 8.18 Mn
Dec 31, 2018 5.33 Mn
Sep 30, 2018 13.27 Mn
Jun 30, 2018 18.24 Mn
Mar 31, 2018 79.80 Mn
Dec 31, 2017 5.02 Mn
Dec 31, 2016 7.00 Mn